Human alpha defensin 5 expression in the human kidney and urinary tract
John David Spencer, David S Hains, Edith Porter, Charles L Bevins, Julianne DiRosario, Brian Becknell, Huanyu Wang, Andrew L Schwaderer, John David Spencer, David S Hains, Edith Porter, Charles L Bevins, Julianne DiRosario, Brian Becknell, Huanyu Wang, Andrew L Schwaderer
Abstract
Background: The mechanisms that maintain sterility in the urinary tract are incompletely understood. Recent studies have implicated the importance of antimicrobial peptides (AMP) in protecting the urinary tract from infection. Here, we characterize the expression and relevance of the AMP human alpha-defensin 5 (HD5) in the human kidney and urinary tract in normal and infected subjects.
Methodology/principal findings: Using RNA isolated from human kidney, ureter, and bladder tissue, we performed quantitative real-time PCR to show that DEFA5, the gene encoding HD5, is constitutively expressed throughout the urinary tract. With pyelonephritis, DEFA5 expression significantly increased in the kidney. Using immunoblot analysis, HD5 production also increased with pyelonephritis. Immunostaining localized HD5 to the urothelium of the bladder and ureter. In the kidney, HD5 was primarily produced in the distal nephron and collecting tubules. Using immunoblot and ELISA assays, HD5 was not routinely detected in non-infected human urine samples while mean urinary HD5 production increased with E.coli urinary tract infection.
Conclusions/significance: DEFA5 is expressed throughout the urinary tract in non-infected subjects. Specifically, HD5 is expressed throughout the urothelium of the lower urinary tract and in the collecting tubules of the kidney. With infection, HD5 expression increases in the kidney and levels become detectable in the urine. To our knowledge, our findings represent the first to quantitate HD5 expression and production in the human kidney. Moreover, this is the first report to detect the presence of HD5 in infected urine samples. Our results suggest that HD5 may have an important role in maintaining urinary tract sterility.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Weichhart T, Haidinger M, Horl WH, Saemann MD. Current concepts of molecular defence mechanisms operative during urinary tract infection. European journal of clinical investigation. 2008;38(Suppl 2):29–38.
- Zasloff M. Antimicrobial peptides, innate immunity, and the normally sterile urinary tract. J Am Soc Nephrol. 2007;18:2810–2816.
- Lehrer RI, Lichtenstein AK, Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol. 1993;11:105–128.
- Valore EV, Ganz T. Posttranslational processing of defensins in immature human myeloid cells. Blood. 1992;79:1538–1544.
- Liu L, Zhao C, Heng HH, Ganz T. The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry. Genomics. 1997;43:316–320.
- Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB, Jr, et al. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest. 1998;101:1633–1642.
- Schroeder BO, Wu Z, Nuding S, Groscurth S, Marcinowski M, et al. Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1. Nature. 2011;469:419–423.
- Lehmann J, Retz M, Harder J, Krams M, Kellner U, et al. Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection. BMC Infect Dis. 2002;2:20.
- Bevins CL. Paneth cell defensins: key effector molecules of innate immunity. Biochemical Society transactions. 2006;34:263–266.
- Quayle AJ, Porter EM, Nussbaum AA, Wang YM, Brabec C, et al. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol. 1998;152:1247–1258.
- Porter E, Yang H, Yavagal S, Preza GC, Murillo O, et al. Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect Immun. 2005;73:4823–4833.
- Com E, Bourgeon F, Evrard B, Ganz T, Colleu D, et al. Expression of antimicrobial defensins in the male reproductive tract of rats, mice, and humans. Biology of reproduction. 2003;68:95–104.
- Porter EM, Poles MA, Lee JS, Naitoh J, Bevins CL, et al. Isolation of human intestinal defensins from ileal neobladder urine. FEBS letters. 1998;434:272–276.
- Townes CL, Ali A, Robson W, Pickard R, Hall J. Tolerance of bacteriuria after urinary diversion is linked to antimicrobial peptide activity. Urology. 2011;77:509 e501–508.
- Wang AP, Su YP, Wang S. Antobacterial acitivity and mechanism of recombinant human alpha defensin 5 agains clinical antibiotic-resistant strains. Afr J Microbiol Res. 2010;4:626–633.
- Gropp R, Frye M, Wagner TO, Bargon J. Epithelial defensins impair adenoviral infection: implication for adenovirus-mediated gene therapy. Human gene therapy. 1999;10:957–964.
- Smith JG, Nemerow GR. Mechanism of adenovirus neutralization by Human alpha-defensins. Cell host & microbe. 2008;3:11–19.
- Dugan AS, Maginnis MS, Jordan JA, Gasparovic ML, Manley K, et al. Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells. The Journal of biological chemistry. 2008;283:31125–31132.
- Zhang D, Liu ZH, Liao QP, Ma JM, Sun YF, et al. Study of local immunity of lower genital tract infections. Zhonghua fu chan ke za zhi. 2009;44:13–15.
- Quayle AJ. The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. Journal of reproductive immunology. 2002;57:61–79.
- Porter EM, van Dam E, Valore EV, Ganz T. Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infection and immunity. 1997;65:2396–2401.
- Chromek M, Slamova Z, Bergman P, Kovacs L, Podracka L, et al. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med. 2006;12:636–641.
- Nitschke M, Wiehl S, Baer PC, Kreft B. Bactericidal activity of renal tubular cells: the putative role of human beta-defensins. Experimental nephrology. 2002;10:332–337.
- Spencer JD, Schwaderer AL, Dirosario JD, McHugh KM, McGillivary G, et al. Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract. Kidney Int 2011
- Ganz T. Defensins in the urinary tract and other tissues. J Infect Dis. 2001;183(Suppl 1):S41–42.
- Ganz T. Antimicrobial proteins and peptides in host defense. Semin Respir Infect. 2001;16:4–10.
- Wehkamp J, Chu H, Shen B, Feathers RW, Kays RJ, et al. Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues. FEBS Lett. 2006;580:5344–5350.
- Cunliffe RN. Alpha-defensins in the gastrointestinal tract. Molecular immunology. 2003;40:463–467.
- Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:18129–18134.
- Quayle AJ, Porter EM, Nussbaum AA, Wang YM, Brabec C, et al. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. The American journal of pathology. 1998;152:1247–1258.
- Hiratsuka T, Nakazato M, Ihi T, Minematsu T, Chino N, et al. Structural analysis of human beta-defensin-1 and its significance in urinary tract infection. Nephron. 2000;85:34–40.
- Tikhonov I, Rebenok A, Chyzh A. A study of interleukin-8 and defensins in urine and plasma of patients with pyelonephritis and glomerulonephritis. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. 1997;12:2557–2561.
- Chon CH, Lai FC, Shortliffe LM. Pediatric urinary tract infections. Pediatric clinics of North America. 2001;48:1441–1459.
- Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, et al. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell. 1997;88:553–560.
- Bals R, Wang X, Wu Z, Freeman T, Bafna V, et al. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. The Journal of clinical investigation. 1998;102:874–880.
- Carone FA, Peterson DR, Flouret G. Renal tubular processing of small peptide hormones. The Journal of laboratory and clinical medicine. 1982;100:1–14.
- Ghosh D, Porter E, Shen B, Lee SK, Wilk D, et al. Paneth cell trypsin is the processing enzyme for human defensin-5. Nature immunology. 2002;3:583–590.
- LiVolsi VA, Clausen KP, Grizzle W, Newton W, Pretlow TG, 2nd, et al. The Cooperative Human Tissue Network. An update. Cancer. 1993;71:1391–1394.
- Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta. 1999;1462:55–70.
- Shen B, Porter EM, Reynoso E, Shen C, Ghosh D, et al. Human defensin 5 expression in intestinal metaplasia of the upper gastrointestinal tract. Journal of clinical pathology. 2005;58:687–694.
- Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P, et al. Aquaporins in the kidney: from molecules to medicine. Physiological reviews. 2002;82:205–244.
- Malagolini N, Cavallone D, Serafini-Cessi F. Intracellular transport, cell-surface exposure and release of recombinant Tamm-Horsfall glycoprotein. Kidney international. 1997;52:1340–1350.
Source: PubMed